无并发症急性B型主动脉夹层标准化药物治疗方案的评估
本研究对比了标准化药物治疗方案实施前后无并发症急性B型主动脉夹层患者的结果。实施后患者总住院时间和重症监护时间缩短,总住院费用、总可变费用和药费降低,出院时所需口服降压药种类减少,30天死亡率无显著差异。
要点
- 标准化方案实施后总住院时间由8.6天缩短至5.5天(P = .02)。
- 方案实施后总住院费用由38928美元降至28066美元(P = .04)。
- 出院时所需口服降压药由3.8种减少至2.7种(P = .005)。
核心结论
- 以目标为导向的标准化药物治疗方案可减少无并发症急性B型主动脉夹层患者的资源利用和费用,且不增加早期死亡率。
研究设计与样本
- 回顾性综述,纳入2016年4月至2020年4月在本机构就诊的急性B型主动脉夹层患者,排除需要主动脉或外周干预者,按方案实施(2018年4月)前后分组比较,共39例(实施前21例,实施后18例)。
主要发现
- 方案实施后组总住院时间8.6天 vs 实施前组5.5天(P = .02),重症监护时间3.2天 vs 1.8天(P = .002)。
- 方案实施后组总住院费用38928美元 vs 实施前组28066美元(P = .04),总可变费用23115美元 vs 15627美元(P = .02),药费5094美元 vs 1181美元(P < .001)。
- 住院护理费用15152美元 vs 11467美元(P = .09),呈下降趋势。
- 方案实施后组出院时所需口服降压药3.8种 vs 2.7种(P = .005)。
- 两组30天死亡率无显著差异;基线人口学特征、收缩压和就诊时急性肾损伤情况相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The goals of medical management for uncomplicated acute type B aortic dissection (TBAD) are to prevent expansion of the false lumen and malperfusion syndrome. This is accomplished with antihypertensive agents, but medication selection and titration are typically provider-dependent. Given the paucity of data on evidence-based management of this population, we hypothesized that a standardized TBAD medical management protocol would reduce resource utilization and costs, without compromising patient outcomes. METHODS: A multidisciplinary team developed a goal-directed protocol to standardize the medical management of uncomplicated acute TBAD, with an emphasis on early initiation of oral medications, weaning of anti-hypertensive infusions, and frequent assessment for de-escalation of care. Implementation was in April 2018. A retrospective review of patients with acute TBAD presenting to our institution from April 2016 to April 2020 was performed. Patients requiring aortic or peripheral intervention were excluded. Included patients were analyzed based on treatment before or after protocol implementation. Patient demographics, systolic blood pressure, presence of acute kidney injury at presentation, length of stay, cost metrics, and 30-day mortality were compared. RESULTS: Thirty-nine patients were included, 21 pre- and 18 post-protocol implementation. Baseline demographics, systolic blood pressure, and presence of acute kidney injury at presentation were similar between the groups. Post-protocol patients had shorter total (8.6 vs 5.5 days; P = .02) and intensive care unit (3.2 vs 1.8 days; P = .002) length of stay. The protocol was associated with significantly decreased total hospital ($38,928 vs $28,066; P = .04), total variable ($23,115 vs $15,627; P = .02), and pharmacy ($5094 vs $1181; P < .001) costs, whereas inpatient care costs ($15,152 vs $11,467; P = .09) trended down. Post-protocol patients required fewer oral antihypertensive agents at discharge (3.8 vs 2.7; P = .005). No significant difference in 30-day mortality was observed. CONCLUSIONS: A goal-directed protocol reduces resource utilization and costs without compromising early mortality rates for patients with uncomplicated acute TBAD. Such a strategy may have broader application in medical management of acute aortic syndromes.
引用
- Aziz A, O'Donnell H, Harris DG, et al. Evaluation of a standardized protocol for medical management of uncomplicated acute type B aortic dissection. J Vasc Surg. 2022. PMID: 35550395. doi:10.1016/j.jvs.2022.03.882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。